Frida Barak

BRCA germline mutations in women with uterine serous carcinoma--still a debate.

Ofer Lavie, Alon Ben‐Arie, Yakir Segev et al. · PubMed · 2010 · 67 citations

The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation

Sharon Hassin‐Baer, Yael Laitman, Esther Azizi et al. · Journal of Neurology · 2009 · 51 citations

Signal Transduction, Molecular Physiology, Somatic Variant +8

Pain control in ambulatory cancer patients—can we do better?

Pesach Shvartzman, Michael Friger, Adi Shani et al. · Journal of Pain and Symptom Management · 2003 · 49 citations

Pain Therapy, Pain Research, Oncology +7

The palliative efficacy of a single high dose of radiation in treatment of symptomatic osseous metastases

Frida Barak, A. Werner, Natalio Walach et al. · International Journal of Radiation Oncology*Biology*Physics · 1987 · 28 citations

Neuro-oncology, Radiation Therapy, Medicine +9

The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients

Frida Barak, Roni Milgrom, Yael Laitman et al. · Gynecologic Oncology · 2010 · 21 citations

Predominant Jewish Mutations, Oncology, Somatic Variant +9